P. Simmonds, J. Bukh, C. Combet, G. Deleage, and N. Enomoto, Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes, Hepatology, vol.17, issue.4, pp.962-973, 2005.
DOI : 10.1002/hep.20819

URL : https://hal.archives-ouvertes.fr/hal-00313678

C. Meffre, E. Delarocque-astagneau, C. Pioche, F. Dubois, and F. Roudot-thoraval, Hepatitis C testing, care and treatment: evolution over ten years in France, Hepatology, vol.46, p.625, 2007.

O. Nainan, M. Alter, D. Kruszon-moran, F. Gao, and G. Xia, Hepatitis C Virus Genotypes and Viral Concentrations in Participants of a General Population Survey in the United States, Gastroenterology, vol.131, issue.2, pp.478-484, 2006.
DOI : 10.1053/j.gastro.2006.06.007

A. Wasley and M. Alter, Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends, Seminars in Liver Disease, vol.20, issue.Number 01, pp.1-16, 2000.
DOI : 10.1055/s-2000-9506

M. Fried, M. Shiffman, K. Reddy, C. Smith, and G. Marinos, Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection, New England Journal of Medicine, vol.347, issue.13, pp.975-982, 2002.
DOI : 10.1056/NEJMoa020047

S. Hadziyannis, H. Sette, . Jr, T. Morgan, V. Balan et al., Peginterferon-??2a and Ribavirin Combination Therapy in Chronic Hepatitis C, Annals of Internal Medicine, vol.140, issue.5, pp.346-355, 2004.
DOI : 10.7326/0003-4819-140-5-200403020-00010

M. Manns, J. Mchutchison, S. Gordon, V. Rustgi, and M. Shiffman, Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial, The Lancet, vol.358, issue.9286, pp.958-965, 2001.
DOI : 10.1016/S0140-6736(01)06102-5

J. Pawlotsky, S. Chevaliez, and J. Mchutchison, The Hepatitis C Virus Life Cycle as a Target for New Antiviral Therapies, Gastroenterology, vol.132, issue.5, pp.1979-1998, 2007.
DOI : 10.1053/j.gastro.2007.03.116

C. Hezode, N. Forestier, G. Dusheiko, P. Ferenci, and S. Pol, Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection, New England Journal of Medicine, vol.360, issue.18, pp.1839-1850, 2009.
DOI : 10.1056/NEJMoa0807650

URL : https://hal.archives-ouvertes.fr/inserm-00385235

P. Kwo, E. Lawitz, J. Mccone, E. Schiff, and J. Vierling, 4 HCV SPRINT-1 FINAL RESULTS: SVR 24 FROM A PHASE 2 STUDY OF BOCEPREVIR PLUS PEGINTRON??? (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN TREATMENT- NAIVE SUBJECTS WITH GENOTYPE-1 CHRONIC HEPATITIS C, Journal of Hepatology, vol.50, p.4, 2009.
DOI : 10.1016/S0168-8278(09)60006-4

J. Mchutchison, G. Everson, S. Gordon, I. Jacobson, and M. Sulkowski, Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection, New England Journal of Medicine, vol.360, issue.18, pp.1827-1838, 2009.
DOI : 10.1056/NEJMoa0806104

A. Erhardt, K. Deterding, Y. Benhamou, M. Reiser, and X. Forns, Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment, Antivir Ther, vol.14, pp.23-32, 2009.

L. Jiang, Y. Gai, T. Middleton, K. Kurtz, and L. Lu, 8 POTENT HCV PROTEASE INHIBITORS WITH THE POTENTIAL FOR ONCE-DAILY DOSING AND BROAD GENOTYPE COVERAGE, Journal of Hepatology, vol.50, issue.1, p.6, 2009.
DOI : 10.1016/S0168-8278(09)60010-6

Y. Liang, H. Ishida, O. Lenz, T. Lin, and O. Nyanguile, Antiviral Suppression vs Restoration of RIG-I Signaling by Hepatitis C Protease and Polymerase Inhibitors, Gastroenterology, vol.135, issue.5, pp.1710-1718, 2008.
DOI : 10.1053/j.gastro.2008.07.023

R. Nettles, C. Chien, E. Chung, A. Persson, and M. Gao, BMS-790052 is a first-in-class potent hepatitis C virus (HCV) NS5A inhibitor for patients with chronic HCV infection: results from a proof-of-concept study, Hepatology, vol.48, p.1025, 2008.

P. Thompson, R. Patel, K. Steffy, and J. Appleman, 90 PRECLINICAL STUDIES OF ANA598 COMBINED WITH OTHER ANTI-HCV AGENTS DEMONSTRATE POTENTIAL OF COMBINATION TREATMENT, Journal of Hepatology, vol.50, issue.1, p.37, 2009.
DOI : 10.1016/S0168-8278(09)60092-1

J. Pawlotsky, Review: Therapeutic implications of hepatitis C virus resistance to antiviral drugs, Therapeutic Advances in Gastroenterology, vol.282, issue.1, pp.205-219, 2009.
DOI : 10.1177/1756283X09336045

M. Mccown, S. Rajyaguru, S. Kular, N. Cammack, and I. Najera, GT-1a or GT-1b Subtype-Specific Resistance Profiles for Hepatitis C Virus Inhibitors Telaprevir and HCV-796, Antimicrobial Agents and Chemotherapy, vol.53, issue.5, pp.2129-2132, 2009.
DOI : 10.1128/AAC.01598-08

T. Kieffer, C. Sarrazin, J. Miller, M. Welker, and N. Forestier, Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients, Hepatology, vol.44, issue.3, pp.631-639, 2007.
DOI : 10.1002/hep.21781

C. Sarrazin, T. Kieffer, D. Bartels, B. Hanzelka, and U. Muh, Dynamic Hepatitis C Virus Genotypic and Phenotypic Changes in Patients Treated With the Protease Inhibitor Telaprevir, Gastroenterology, vol.132, issue.5, pp.1767-1777, 2007.
DOI : 10.1053/j.gastro.2007.02.037

S. Villano, A. Howe, D. Raible, D. Harper, and J. Speth, Analysis of HCV NS5B genetic variants following monotherapy with HCV-796, a non-nucleoside polymerase inhibitor, in treatment-naive HCV-infected patients, Hepatology, vol.44, issue.1, pp.607-608, 2006.

S. Chevaliez and J. Pawlotsky, Diagnosis and management of chronic viral hepatitis: Antigens, antibodies and viral genomes, Best Practice & Research Clinical Gastroenterology, vol.22, issue.6, pp.1031-1048, 2008.
DOI : 10.1016/j.bpg.2008.11.004

URL : https://hal.archives-ouvertes.fr/inserm-00368349

P. Simmonds, E. Holmes, T. Cha, S. Chan, and F. Mcomish, Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region, Journal of General Virology, vol.74, issue.11, pp.2391-2399, 1993.
DOI : 10.1099/0022-1317-74-11-2391

J. Bronowicki, D. Ouzan, T. Asselah, H. Desmorat, and J. Zarski, Effect of Ribavirin in Genotype 1 Patients With Hepatitis C Responding to Pegylated Interferon Alfa-2a Plus Ribavirin, Gastroenterology, vol.131, issue.4, pp.1040-1048, 2006.
DOI : 10.1053/j.gastro.2006.07.022

P. Qiu, X. Cai, W. Ding, Q. Zhang, and E. Norris, HCV genotyping using statistical classification approach, Journal of Biomedical Science, vol.16, issue.1, p.62, 2009.
DOI : 10.1186/1423-0127-16-62

URL : http://doi.org/10.1186/1423-0127-16-62

Z. Chen and K. Weck, Hepatitis C Virus Genotyping: Interrogation of the 5' Untranslated Region Cannot Accurately Distinguish Genotypes 1a and 1b, Journal of Clinical Microbiology, vol.40, issue.9, pp.3127-3134, 2002.
DOI : 10.1128/JCM.40.9.3127-3134.2002

R. Ross, S. Viazov, and M. Roggendorf, Genotyping of hepatitis C virus isolates by a new line probe assay using sequence information from both the 5???untranslated and the core regions, Journal of Virological Methods, vol.143, issue.2, pp.153-160, 2007.
DOI : 10.1016/j.jviromet.2007.03.006

F. Bouchardeau, J. Cantaloube, S. Chevaliez, C. Portal, and A. Razer, Improvement of Hepatitis C Virus (HCV) Genotype Determination with the New Version of the INNO-LiPA HCV Assay, Journal of Clinical Microbiology, vol.45, issue.4, pp.1140-1145, 2007.
DOI : 10.1128/JCM.01982-06

URL : https://hal.archives-ouvertes.fr/hal-01076948

F. Nolte, A. Green, K. Fiebelkorn, A. Caliendo, and C. Sturchio, Clinical Evaluation of Two Methods for Genotyping Hepatitis C Virus Based on Analysis of the 5' Noncoding Region, Journal of Clinical Microbiology, vol.41, issue.4, pp.1558-1564, 2003.
DOI : 10.1128/JCM.41.4.1558-1564.2003

J. Verbeeck, M. Stanley, J. Shieh, L. Celis, and E. Huyck, Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0, Journal of Clinical Microbiology, vol.46, issue.6, pp.1901-1906, 2008.
DOI : 10.1128/JCM.02390-07

E. Martro, V. Gonzalez, A. Buckton, V. Saludes, and G. Fernandez, Evaluation of a New Assay in Comparison with Reverse Hybridization and Sequencing Methods for Hepatitis C Virus Genotyping Targeting Both 5' Noncoding and Nonstructural 5b Genomic Regions, Journal of Clinical Microbiology, vol.46, issue.1, pp.192-197, 2008.
DOI : 10.1128/JCM.01623-07

Y. Morice, D. Roulot, V. Grando, J. Stirnemann, and E. Gault, Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns, Journal of General Virology, vol.82, issue.5, pp.1001-1012, 2001.
DOI : 10.1099/0022-1317-82-5-1001

J. Felsenstein, PHYLIP: phylogeny inference package, version 3.5c (computer program) Distributed by the author, 1993.

J. Thompson, D. Higgins, and T. Gibson, CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice, Nucleic Acids Research, vol.22, issue.22, pp.4673-4680, 1994.
DOI : 10.1093/nar/22.22.4673

M. Salemi and A. Vandamme, Hepatitis C Virus Evolutionary Patterns Studied Through Analysis of Full-Genome Sequences, Journal of Molecular Evolution, vol.54, issue.1, pp.62-70, 2002.
DOI : 10.1007/s00239-001-0018-9

D. Huson, D. Richter, C. Rausch, T. Dezulian, and M. Franz, Dendroscope: An interactive viewer for large phylogenetic trees, BMC Bioinformatics, vol.8, issue.1, p.460, 2007.
DOI : 10.1186/1471-2105-8-460

G. Perriere and M. Gouy, WWW-query: An on-line retrieval system for biological sequence banks, Biochimie, vol.78, issue.5, pp.364-369, 1996.
DOI : 10.1016/0300-9084(96)84768-7

URL : https://hal.archives-ouvertes.fr/hal-00435034